科笛-B(02487.HK)獲首席財務官兼執行董事黃雨青斥資74.77萬港元增持公司股份
格隆匯10月8日丨科笛-B(02487.HK)公佈,公司董事會接獲首席財務官兼執行董事黃雨青的通知,彼於2024年10月2日及3日以其個人資金於公開市場上購買合共5萬股股份,總代價為約747,684港元,相當於每股股份平均價格約14.954港元。
黃雨青表示,增持股份反映其對公司的業務前景及展望充滿信心。在遵守適用法律及監管規定的情況下,黃雨青不排除考慮於適當時機進一步增持公司股份的可能性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.